NCT05743569Active, not recruiting
3D Specimen Maps for RT Planning
Virtual Patient-specific 3D Specimen Maps for Adjuvant Head & Neck Radiotherapy Planning
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
The primary objective of this study is to measure the impact of patient-specific 3D specimen maps on adjuvant radiation treatment volumes and doses to critical organs. All patients will receive standard-of-care post-operative radiotherapy not impacted by the experimental 3D specimen maps. The secondary objective is to demonstrate the feasibility of incorporating 3D specimen mapping tools into post-operative communication, and to determine if utilization of the 3D specimen map improves post-operative communication between surgeons, pathologists, and radiation oncologists.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 13 (estimated)
- First submitted
- 14 Feb 2023
- Start date
- 26 Jan 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Vanderbilt University Medical Center
- Diseases
- Head and neck cancer
- NCT number
- NCT05743569
What you commit to
- Study type: Observational
- Planned participants: 13
- From 26 Jan 2023 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with contraindications to radiotherapy
Other illness
- Cutaneous malignancies
Age
- Under the age of 18
Other
- Characteristics that make the process of informed consent questionable
- Pregnant women
Who the study is looking for
- Over the age of 18
- Biopsy-confirmed mucosal head and neck cancer. All histologic malignancies will be included.
- Patients who have completed primary tumor surgical resection in the following anatomic subsites:
- oral cavity (oral tongue, floor of mouth, hard palate, buccal mucosa, retromolar trigone, maxillary and mandibular alveolus, lip)
- oropharynx (soft palate, base of tongue, palatine tonsils)
- hypopharynx (piriform sinus, post-cricoid, posterior pharyngeal wall)
- larynx (supraglottic, glottic, subglottic);
- Patients who have consented to 3D specimen mapping on protocol IRB # 221597 and for whom 3D specimen maps are therefore available.
- Patients are indicated to receive curative-intent post-operative radiotherapy and intend to receive radiotherapy at Vanderbilt University Medical Center or Vanderbilt Ingram Cancer Center sites in Nashville, Franklin, or Lebanon
Age in the registry: 28 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.